These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
573 related items for PubMed ID: 19861864
1. The effect of use of dates on serum potassium in nondiabetic hemodialysis patients. Siddiqi N, El Shahat O, Bokhari E, Roujouleh H, Hamid MH, Sheikh I, El-Sayed H, Saleh A, Seddik A. Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1018-22. PubMed ID: 19861864 [Abstract] [Full Text] [Related]
2. Prevalence of hyperkalemia among hemodialysis patients in Egypt. Khedr E, Abdelwhab S, El-Sharkawy M, Ali M, El Said K. Ren Fail; 2009 Nov; 31(10):891-8. PubMed ID: 20030523 [Abstract] [Full Text] [Related]
3. A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients. Kaisar MO, Wiggins KJ, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Mudge DW, Bofinger A, Petrie JJ, Johnson DW. Am J Kidney Dis; 2006 May; 47(5):809-14. PubMed ID: 16632019 [Abstract] [Full Text] [Related]
4. Electrocardiographic manifestations of hyperkalemia in hemodialysis patients. Nemati E, Taheri S. Saudi J Kidney Dis Transpl; 2010 May; 21(3):471-7. PubMed ID: 20427871 [Abstract] [Full Text] [Related]
5. Electrocardiography and serum potassium before and after hemodialysis sessions. Tarif N, Yamani H, Bakhsh AJ, Al-Wakeel JS, Sulaimani F, Memon NA, Al Suwaida AK. Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):47-53. PubMed ID: 18087122 [Abstract] [Full Text] [Related]
6. Potassium-lowering effect of albuterol for hyperkalemia in renal failure. Montoliu J, Lens XM, Revert L. Arch Intern Med; 1987 Apr; 147(4):713-7. PubMed ID: 3827459 [Abstract] [Full Text] [Related]
7. Adherence to treatment and hospitalization risk in hemodialysis patients. Vaiciuniene R, Kuzminskis V, Ziginskiene E, Skarupskiene I, Bumblyte IA. J Nephrol; 2012 Apr; 25(5):672-8. PubMed ID: 21983989 [Abstract] [Full Text] [Related]
8. Extreme hyperglycemia with ketoacidosis and hyperkalemia in a patient on chronic hemodialysis. Gupta A, Rohrscheib M, Tzamaloukas AH. Hemodial Int; 2008 Oct; 12 Suppl 2():S43-7. PubMed ID: 18837770 [Abstract] [Full Text] [Related]
9. The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients. Heguilén RM, Sciurano C, Bellusci AD, Fried P, Mittelman G, Rosa Diez G, Bernasconi AR. Nephrol Dial Transplant; 2005 Mar; 20(3):591-7. PubMed ID: 15687112 [Abstract] [Full Text] [Related]
10. Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. Ngugi NN, McLigeyo SO, Kayima JK. East Afr Med J; 1997 Aug; 74(8):503-9. PubMed ID: 9487416 [Abstract] [Full Text] [Related]
11. Long-term low-dose spironolactone therapy is safe in oligoanuric hemodialysis patients. Matsumoto Y, Kageyama S, Yakushigawa T, Arihara K, Sugiyama T, Mori Y, Sugiyama H, Ohmura H, Shio N. Cardiology; 2009 Aug; 114(1):32-8. PubMed ID: 19342857 [Abstract] [Full Text] [Related]
12. The efficiency of potassium removal during bicarbonate hemodialysis. Capdevila M, Ruiz IM, Ferrer C, Monllor F, Ludjvick C, García NH, Juncos LI. Hemodial Int; 2005 Jul; 9(3):296-302. PubMed ID: 16191080 [Abstract] [Full Text] [Related]
13. [The ECG changes during the performance of hemodialysis using dialysis solution concentrates with different potassium levels in patients with chronic kidney failure and normokalemia]. Alavi AA, Riabykina GV, Zaruba AIu, Kutsenko AI, Kukharchuk VV, Eliseev AO. Ter Arkh; 1993 Jul; 65(4):58-60. PubMed ID: 8059409 [Abstract] [Full Text] [Related]
14. Effect of acetate-free biofiltration with a potassium-profiled dialysate on the control of cardiac arrhythmias in patients at risk: a pilot study. Muñoz RI, Montenegro J, Salcedo A, Gallardo I, Martínez I, Quintanilla N, Saracho R, Lekuona I. Hemodial Int; 2008 Jan; 12(1):108-13. PubMed ID: 18271851 [Abstract] [Full Text] [Related]
15. Excessive watermelon consumption causing hyperkalaemia and increased symptom burden of an end stage renal disease patient. Chan KY, Yap DY, Li CW, Cheng HW, Au HY. Nephrology (Carlton); 2016 Aug; 21(8):721. PubMed ID: 27436619 [No Abstract] [Full Text] [Related]
16. Potassium management in pediatric peritoneal dialysis patients: can a diet with increased potassium maintain a normal serum potassium without a potassium supplement? Factor KF. Adv Perit Dial; 2007 Aug; 23():167-9. PubMed ID: 17886626 [Abstract] [Full Text] [Related]
17. Management of hyperkalemia in dialysis patients. Putcha N, Allon M. Semin Dial; 2007 Aug; 20(5):431-9. PubMed ID: 17897250 [Abstract] [Full Text] [Related]